vaccine preparedness, hesitancy and adverse event surveillance - cdc perspective | elliot raizes, md
Published 3 years ago • 107 plays • Length 8:42Download video MP4
Download video MP3
Similar videos
-
59:23
what clinicians need to know about pfizer-biontech and moderna vaccines
-
0:32
adolescents now eligible for covid-19 vaccination
-
8:40
vaccine hesitancy and herd immunity
-
3:52
the rise of vaccine hesitancy
-
8:24
vaccine hesitancy: past, present, and future
-
0:38
covid-19 vaccines and rural communities
-
4:16
the broad spectrum of presentations of individuals with an igg4-related disease
-
58:56
february 28, 2021 acip meeting - grade: janssen covid-19 vaccine
-
0:53
potential strategies to prevent the evolution of ccus to mds
-
4:18
immunization remains an unfinished business
-
6:32
vaccines for all age groups needed to control pandemic: medical expert
-
6:19
coronavirus vaccine hesitancy can lead to development of ‘potent mutations’ with covid-19: doctor
-
6:17
the difference between a vaccine expiration date and beyond-use date or time
-
4:27
chapter 4, part b: potential serious adverse events
-
2:10
the summit trial: bezuclastinib in adult patients with non-advanced systemic mastocytosis
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
53:26
ethealthworld webinar : role of vaccines in reducing the disease burden
-
5:59
gynecological cancer 101 with eric rios-doria, md
-
1:45
infectious diseases a-z: what are the risks of getting vaccinated?